<- Go Home
JW Lifescience Corporation
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
Market Cap
KRW 173.3B
Volume
57.9K
Cash and Equivalents
KRW 8.9B
EBITDA
KRW 52.0B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 72.9B
Profit Margin
28.84%
52 Week High
KRW 15.6K
52 Week Low
KRW 10.6K
Dividend
N/A
Price / Book Value
0.79
Price / Earnings
5.94
Price / Tangible Book Value
1.22
Enterprise Value
KRW 203.3B
Enterprise Value / EBITDA
3.91
Operating Income
KRW 33.4B
Return on Equity
13.98%
Return on Assets
6.53
Cash and Short Term Investments
KRW 12.2B
Debt
KRW 42.3B
Equity
KRW 218.7B
Revenue
KRW 252.7B
Unlevered FCF
KRW 24.7B
Sector
Pharmaceuticals
Category
N/A